Epinephrine stimulates inositol phospholipid metabolism by activating alpha-2 adrenergic receptors in human platelets.

[1]  J. Piletz,et al.  Evaluation of studies on platelet alpha 2 adrenoreceptors in depressive illness. , 1986, Life sciences.

[2]  J. Sweatt,et al.  Inhibitors of Na+/H+ exchange block epinephrine- and ADP-induced stimulation of human platelet phospholipase C by blockade of arachidonic acid release at a prior step. , 1986, The Journal of biological chemistry.

[3]  J. García-Sevilla,et al.  Labelling of human platelet α2-adrenoceptors with the full agonist [3H](−)adrenaline , 1986 .

[4]  M. Maguire,et al.  Alpha 2-adrenoceptor coupling to adenylate cyclase in adrenaline insensitive human platelets. , 1985, European journal of pharmacology.

[5]  K. Minneman,et al.  α1-Adrenergic receptors and stimulation of [3H]inositol metabolism in rat brain: Regional distribution and parallel inactivation , 1985, Brain Research.

[6]  D. Kendall,et al.  Alpha 1-adrenoceptor-mediated inositol phospholipid hydrolysis in rat cerebral cortex: relationship between receptor occupancy and response and effects of denervation. , 1985, European journal of pharmacology.

[7]  E. Lapetina,et al.  Collagen stimulates [3H]inositol trisphosphate formation in indomethacin-treated human platelets. , 1985, The Biochemical journal.

[8]  R. A. Akhtar,et al.  Carbachol causes rapid phosphodiesteratic cleavage of phosphatidylinositol 4,5-bisphosphate and accumulation of inositol phosphates in rabbit iris smooth muscle; prazosin inhibits noradrenaline- and ionophore A23187-stimulated accumulation of inositol phosphates. , 1984, The Biochemical journal.

[9]  E. Lapetina,et al.  The rapid formation of inositol phosphates in human platelets by thrombin is inhibited by prostacyclin. , 1984, The Journal of biological chemistry.

[10]  B. Roufogalis,et al.  Comparison of muscarinic and alpha-adrenergic receptors in rat atria based on phosphoinositide turnover. , 1984, Life Science.

[11]  N. Thompson,et al.  Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets. , 1984, British journal of pharmacology.

[12]  M. Berridge,et al.  The second messenger linking receptor activation to internal Ca release in liver , 1984, Nature.

[13]  Y. Nishizuka.  The role of protein kinase C in cell surface signal transduction and tumour promotion , 1984, Nature.

[14]  M. J. Berridge,et al.  Release of Ca2+ from a nonmitochondrial intracellular store in pancreatic acinar cells by inositol-1,4,5-trisphosphate , 1983, Nature.

[15]  M. Berridge,et al.  Changes in the levels of inositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. , 1983, The Biochemical journal.

[16]  G. Mauco,et al.  Platelet activating factor (PAF‐acether) promotes an early degradation of phosphatidylinositol‐4,5‐biphosphate in rabbit platelets , 1983, FEBS letters.

[17]  B. Agranoff,et al.  Thrombin-induced phosphodiesteratic cleavage of phosphatidylinositol bisphosphate in human platelets. , 1983, The Journal of biological chemistry.

[18]  Y. Nishizuka,et al.  A role of calcium-activated phospholipid-dependent protein kinase in human platelet activation. Comparison of thrombin and collagen actions. , 1983, The Journal of biological chemistry.

[19]  J. Mustard,et al.  Changes in phosphatidylinositol-4,5-bisphosphate 10 seconds after stimulation of washed rabbit platelets with ADP , 1982 .

[20]  E. Lapetina,et al.  Rapid decrease of phosphatidylinositol 4,5-bisphosphate in thrombin-stimulated platelets. , 1982, The Journal of biological chemistry.

[21]  M. Berridge,et al.  Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. , 1982, The Biochemical journal.

[22]  S. Schanberg,et al.  Involvement of alpha noradrenergic receptors in mediation of brain polyphosphoinositides metabolism in vivo. , 1982, The Journal of pharmacology and experimental therapeutics.

[23]  M. Scrutton,et al.  Novel α2-adrenoreceptors primarily responsible for inducing human platelet aggregation , 1979, Nature.

[24]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[25]  R. Haslam,et al.  Effects of catecholamines on the formation of adenosine 3':5'-cyclic monophosphate in human blood platelets. , 1971, The Biochemical journal.

[26]  E. Salzman,et al.  Cyclic 3′,5′-Adenosine Monophosphate in Human Blood Platelets , 1969, Nature.

[27]  P. Weber,et al.  Activation of V1-receptors by vasopressin stimulates inositol phospholipid hydrolysis and arachidonate metabolism in human platelets. , 1986, The Biochemical journal.

[28]  J. Guimón,et al.  Biochemical and functional evidence of supersensitive platelet alpha 2-adrenoceptors in major affective disorder. Effect of long-term lithium carbonate treatment. , 1986, Archives of general psychiatry.